BNET Industries

Perrigo Co.

(PRGO) is in the Pharma Industry

Market Cap:$3.5B
Last Fiscal Year Sales:$1.8B
  • Public
  • US
Dow Jones Description

Perrigo Company, established in 1887, is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the worlds largest manufacturer of OTC pharmaceutical products for the store brand market. The Companys primary markets and locations of manufacturing and logistics operations are the United States (U.S.), Israel, Mexico and the United Kingdom (U.K.). See Note 17 to the Companys consolidated financial statements for further information. Perrigo Company operates through several wholly owned subsidiaries. In the U.S., its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., Perrigo Holland, Inc. (formerly J.B. Laboratories, Inc.) and Perrigo Florida, Inc. (formerly Unico Holdings, Inc.). Outside the U.S., its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Brunel Pharma Limited (formerly Brunel Healthcare Ltd.) and Galpharm Healthcare Ltd. As used herein, references to the Company means Perrigo Company, its subsidiaries and all predecessors of Perrigo Company and its subsidiaries.

Number of Employees 6,200
Contact Information

515 Eastern Ave

Allegan, Michigan 49010-9070

perrigo.com

(269) 673-8451

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Business headlines: Saab, Swedes look for buyer

    12/01/09 - Lawsuit Filed - View Story

  • Flu, economy boost drug maker Perrigo

    11/20/09 - Financial Announcement - View Story

  • Arkin investment NeurogesX gets FDA approval for patch: Mori Arkin owns 15% of the US...

    11/17/09 - Merger / Acquisition - View Story

  • Todays Zacks Rank Growth and Income Buy: Ross Stores, Inc.

    11/09/09 - Financial Announcement - View Story

  • NPI Watch - Nov. 2, 2009 - Editorial: Dr. Joshua Sharfstein at the Annual...

    11/03/09 - Stock Split / Dividend - View Story

  • Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009

    10/19/09 - Financial Announcement - View Story

  • Bank of America Maintains a 'Buy' on Perrigo Company PRGO; Raises PT

    9/30/09 - Bond / Stock Rating - View Story

  • UPDATE 1-Perrigo buys KV Pharma filing for generic acne gel

    9/21/09 - Merger / Acquisition - View Story

  • Expansion anticipated as Perrigo enters new fiscal year

    8/30/09 - Financial Announcement - View Story

  • Perrigo gears up for cough/cold season

    8/20/09 - Product Announcement - View Story

  • Perrigo posts $144M profit

    8/19/09 - Financial Announcement - View Story

News & Analysis

healthcare and perrigo co. - All News and Analysis

advertisement
Click Here
     PRGO $38.89 -0.33 (-0.84% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 849,141
Shares Outstanding 91.33M
Market Cap 3.6B
Year High 40.94
Year Low 18.54
Earnings Per Share 1.77
P/E Ratio 21.97
Dividend 0.25
Yield 0.64
Glass Door

Perrigo

CEO Rating

Joseph C. Papa

Chairman, President, and CEO

100% Approve

Employer Rating
“Very Satisfied!” 4.0 3.0
Employee Reviews
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Presented by American Express